Tchaikapharma High Quality Medicines AD (BUL:THQM)

Bulgaria · Delayed Price · Currency is BGN · Price in EUR

6.70

-0.05 (-0.74%)

At close: Jul 31, 2026

BUL:THQM Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	34.7	32.74	27.24	24.8	22.06	21.7
Revenue Growth	21.39%	20.17%	9.83%	12.46%	1.65%	5.84%
Gross Profit	28.09	23.51	19.1	7.66	15.51	5.97
Operating Income	4.14	3.36	2.7	2.05	1.56	0.75
Net Income	3.85	3.08	2.3	1.74	1.43	0.71
Earnings Per Share	0.04	0.03	0.02	0.02	0.01	0.01
EPS Growth	46.43%	33.64%	28.07%	21.89%	99.78%	137.53%

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Bulgaria	33.32	31.76	25.97	24.06	21.39	21.4
European Union	-	0.71	0.82	0.43	0.39	0.19
Exports	0.51	0.21	0.38	0.29	0.25	0.09
Total	34.65	32.69	27.17	24.77	22.03	21.68

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.1	0.61	0.07	0.03	0.07	0.03
Total Debt	5.12	6.02	5.7	5.71	6.03	6.39
Net Cash (Debt)	-5.02	-5.41	-5.63	-5.68	-5.96	-6.36
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.05	-0.05	-0.06	-0.06	-0.06	-0.06

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2.04	1.83	1.72	1.47	1.26	1.03
Capital Expenditures	-0.41	-0.56	-1.11	-0.98	-0.81	-0.8
Free Cash Flow	1.62	1.27	0.61	0.49	0.45	0.23
Free Cash Flow Growth	196.03%	106.85%	25.46%	8.42%	95.70%	-22.25%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	80.98%	71.81%	70.12%	30.87%	70.31%	27.49%
Operating Margin	11.95%	10.26%	9.92%	8.26%	7.06%	3.43%
Pretax Margin	12.07%	10.38%	9.47%	7.98%	7.26%	3.69%
Profit Margin	11.11%	9.40%	8.45%	7.01%	6.47%	3.29%
FCF Margin	4.68%	3.87%	2.25%	1.97%	2.04%	1.06%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	176.14	292.92	367.12	443.67	487.62	901.80
P/FCF Ratio	417.15	711.08	1379.40	1579.55	1544.21	2797.58
PS Ratio	19.52	27.52	31.02	31.10	31.53	29.67